tirzepatide 7.5 mg/0.5 ml pen injector Mounjaro (Tirzepatide) Injection Prefilled Syringes (4-Pack) **Refrigeration Required (RX) Mounjaro (Tirzepatide) is administered as a subcutaneous injection once a week Tirzepatide Zepbound 7.5mg Vial 0.5ml

doi:10.1002/hep.23569 Targher G, Mantovani A, Byrne CD

They are offered as part of a broader wellness strategy and are not intended to diagnose, treat, cure, or prevent disease

Listening to others who have walked the same path can provide valuable insights and empathy

Sleep feels less restorative

Prior authorization requirements may need to be met before coverage begins

Tirzepatides design deliberately exploits both incretin axes: GLP-1 receptor activation promotes satiety, slows gastric emptying, and enhances glucose-dependent insulin secretion, while GIP receptor engagement appears to amplify insulin responses and may contribute independently to adipose tissue metabolism